LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Начало・Списък с акции・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

558.69 1.39

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

545.4

Максимум

577

Ключови измерители
By Trading Economics
Приходи	-72M -114M
Продажби	74M 287M
EPS	-4.956
Марж на печалбата	-39.75
Служители	528
EBITDA	-75M -114M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	-4.77% downside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	3.4B 13B
Предишно отваряне	557.3
Предишно затваряне	558.69

Настроения в новините

By Acuity

30%

70%

77 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

263.2 / 277.1 Подкрепа & съпротива

Madrigal Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.11.2025 г., 19:25 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18.11.2025 г., 18:09 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18.11.2025 г., 17:39 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18.11.2025 г., 16:25 ч. UTC

Значими двигатели на пазара

Diginex Rises on Deal With Digital Asset Platform Evident

18.11.2025 г., 23:56 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18.11.2025 г., 23:39 ч. UTC

Пазарно говорене

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18.11.2025 г., 22:59 ч. UTC

Пазарно говорене

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18.11.2025 г., 22:08 ч. UTC

Пазарно говорене

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18.11.2025 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18.11.2025 г., 22:03 ч. UTC

Печалби

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

18.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

18.11.2025 г., 21:15 ч. UTC

Пазарно говорене

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18.11.2025 г., 20:46 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18.11.2025 г., 20:13 ч. UTC

Пазарно говорене

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18.11.2025 г., 19:48 ч. UTC

Пазарно говорене

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18.11.2025 г., 18:29 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18.11.2025 г., 18:18 ч. UTC

Пазарно говорене

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

18.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

18.11.2025 г., 17:19 ч. UTC

Пазарно говорене

Печалби

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18.11.2025 г., 17:06 ч. UTC

Печалби

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18.11.2025 г., 16:06 ч. UTC

Придобивния, сливания и поглъщания

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18.11.2025 г., 15:59 ч. UTC

Печалби

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18.11.2025 г., 15:35 ч. UTC

Придобивния, сливания и поглъщания

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18.11.2025 г., 15:35 ч. UTC

Придобивния, сливания и поглъщания

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Сравнение с други в отрасъла

Ценова промяна

Madrigal Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

-4.77% надолу

12-месечна прогноза

Среден 527 USD -4.77%

Висок 590 USD

Нисък 392 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Madrigal Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

15 ratings

Купи

Задържане

Продай

Според 15 анализатори, дали борсови рейтинги на Madrigal Pharmaceuticals Inc през последните 3 месеца.

Техническа оценка

By Trading Central

263.2 / 277.1Подкрепа & съпротива

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Настроение

By Acuity

77 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.